These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34445034)

  • 1. A New Disease Concept in the Age of Processed Foods-Phosphorus-Burden Disease; including CKD-MBD Concrete Analysis and the Way to Solution.
    Nishime K; Sugiyama N; Okada K
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing dietary phosphorus intake from food additives: potential for negative impact on bone health.
    Takeda E; Yamamoto H; Yamanaka-Okumura H; Taketani Y
    Adv Nutr; 2014 Jan; 5(1):92-7. PubMed ID: 24425727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study.
    Neri L; Kreuzberg U; Bellocchio F; Brancaccio D; Barbieri C; Canaud B; Stuard S; Ketteler M
    Nephrol Dial Transplant; 2019 Apr; 34(4):682-691. PubMed ID: 30165528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caring for chronic kidney disease patients: focus on mineral and bone disorders.
    Nguyen TV; Filson J
    Consult Pharm; 2009 Feb; 24(2):146-52. PubMed ID: 19275456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.
    Ketteler M; Block GA; Evenepoel P; Fukagawa M; Herzog CA; McCann L; Moe SM; Shroff R; Tonelli MA; Toussaint ND; Vervloet MG; Leonard MB
    Kidney Int; 2017 Jul; 92(1):26-36. PubMed ID: 28646995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kidney and bone update : the 5-year history and future of CKD-MBD. About the guideline of the Japanese Society for Dialysis Therapy].
    Yokoyama K
    Clin Calcium; 2012 Jul; 22(7):979-86. PubMed ID: 22750929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
    Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Habitual high phosphorus intakes and foods with phosphate additives negatively affect serum parathyroid hormone concentration: a cross-sectional study on healthy premenopausal women.
    Kemi VE; Rita HJ; Kärkkäinen MU; Viljakainen HT; Laaksonen MM; Outila TA; Lamberg-Allardt CJ
    Public Health Nutr; 2009 Oct; 12(10):1885-92. PubMed ID: 19216809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphate, Microbiota and CKD.
    Favero C; Carriazo S; Cuarental L; Fernandez-Prado R; Gomá-Garcés E; Perez-Gomez MV; Ortiz A; Fernandez-Fernandez B; Sanchez-Niño MD
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
    Jean G; Daugas É; Roth H; Drueke T; Bouchet JL; Hannedouche T; London G; Fouque D
    Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Information about phosphorus additives and nutritional counseling].
    Kido S; Nomura K; Sasaki S; Shiozaki Y; Segawa H; Tatsumi S
    Clin Calcium; 2012 Oct; 22(10):1583-91. PubMed ID: 23023640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease.
    Kalantar-Zadeh K; Gutekunst L; Mehrotra R; Kovesdy CP; Bross R; Shinaberger CS; Noori N; Hirschberg R; Benner D; Nissenson AR; Kopple JD
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):519-30. PubMed ID: 20093346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters.
    Roetker NS; Peng Y; Ashfaq A; Gilbertson DT; Wetmore JB
    Am J Nephrol; 2019; 49(3):225-232. PubMed ID: 30820015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.
    Palmer SC; Teixeira-Pinto A; Saglimbene V; Craig JC; Macaskill P; Tonelli M; de Berardis G; Ruospo M; Strippoli GF
    Am J Kidney Dis; 2015 Dec; 66(6):962-71. PubMed ID: 26003472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most consumed processed foods by patients on hemodialysis: Alert for phosphate-containing additives and the phosphate-to-protein ratio.
    Watanabe MT; Araujo RM; Vogt BP; Barretti P; Caramori JCT
    Clin Nutr ESPEN; 2016 Aug; 14():37-41. PubMed ID: 28531397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "phosphorus pyramid": a visual tool for dietary phosphate management in dialysis and CKD patients.
    D'Alessandro C; Piccoli GB; Cupisti A
    BMC Nephrol; 2015 Jan; 16():9. PubMed ID: 25603926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
    Ketteler M; Sprague SM; Covic AC; Rastogi A; Spinowitz B; Rakov V; Walpen S; Floege J
    Nephrol Dial Transplant; 2019 Jul; 34(7):1163-1170. PubMed ID: 29846719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CKD-MBD biomarkers and CKD progression: an analysis by the joint model.
    D'Arrigo G; Mallamaci F; Pizzini P; Leonardis D; Tripepi G; Zoccali C
    Nephrol Dial Transplant; 2023 Mar; 38(4):932-938. PubMed ID: 35790138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.